The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.

ABSTRACT:

SUBMITTER: Stadler N 

PROVIDER: S-EPMC5477622 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature